Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 7Unknown 5Recruiting 3Terminated 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 18Gastrointestinal 8Lymphoid 7Other hematologic neoplasm 6Genitourinary 6Tumor-Agnostic 5Thoracic 5Gynecologic 3Other 2Head & Neck 2Dermatologic 2CNS 2Plasma cell 1Myeloid 1Classical hematology 1

Conditions

Ovarian Neoplasms 2Endometrial Neoplasms 2

Interventions

Paclitaxel 81Carboplatin 67pembrolizumab 62Bevacizumab 58Cisplatin 49Specimen Handling 29Drug Therapy 26Blood Specimen Collection 23olaparib 20Cyclophosphamide 18Taxes 17Magnetic Resonance Spectroscopy 16Letrozole 16Gemcitabine 16Biopsy 16liposomal doxorubicin 15niraparib 14Brachytherapy 14fludarabine 13Radiotherapy 13abemaciclib 12Injections 12Topotecan 11Nivolumab 11Doxorubicin 11lenvatinib 10Fulvestrant 10Fluorouracil 10Surveys and Questionnaires 9Standard of Care 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Exercise × Gynecologic × Clear all
NCT04997096 2026-02-19

Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy

Dana-Farber Cancer Institute

Phase NA Recruiting
30 enrolled
Gynecologic

Ovarian Neoplasms, Endometrial Neoplasms

NCT07025213 2025-06-17

Metabolic Effect of Exercise and Diet in Endometrial Cancer Patients Eligible for Staging Surgery.

National Institute of Cancerología

Phase NA Recruiting
80 enrolled
Gynecologic

Endometrial Neoplasms

NCT05761561 2025-06-03

TEAL

Yale University

Phase NA Recruiting
200 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡